Uniphar said it had acquired Nordic-based medtech service provider EPS and Ireland-based rival M3 Medical for a combined up to €40m. The acquisition sum would be paid over four years, with a deferred consideration to be linked to operating earnings performance over that period. 'This cluster of acquisitions represent another important development in the roll-out of Uniphar's pan-European growth strategy for its commercial and clinical division,' the company said. At 8:00am: (LON:UPR) share price was 0p at 1.2p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.